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Background
Definitions. Aggression types. Therapeutic methods for
coping aggression.
Assessment of the drug effect in aggressive patients with
different nosological belonging.
Materials and methods
Three groups of patients /aggressive patients with schizo-
phrenia, potentially aggressive patients with schizophre-
nia and aggressive patients with personal disorder/ age 18-
60, without any significant somatic diseases, with diagno-
sis paranoid schizophrenia and personal disorder, are
studied. Clozapine is applied in variable doses. A battery
of psychological tests for aggression assessment is used.
Personality evaluation was made by IPDE for patients
with personality disorders. Diagnostic procedures
included ICD-10 criteria.
Results
There is a considerable reduction of aggressive behaviour
by fast dosage titration of Clozapine. The side effects affect
significantly the patients' compliance
Conclusions
It is observed a good compliance in low Clozapine dosage
(under 100 mg.). We consider that the better compliance
is also linked with a regular blood count providing thera-
peutic contacts with patients.
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